Letter: Gender-associated cell-free microRNA profiles in non-alcoholic fatty liver disease

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 9, 2014, Pages 997-998

  Longchamps, R J ^a   Abey, S K ^a   Martino, A C ^a   Henderson, W A ^a  

^a Division of Intramural Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYTOKINE; ESTROGEN; HSA MIR 155 5P; HSA MIR 301B; HSA MIR 432 5P; HSA MIR 578; MICRORNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; COMPARATIVE STUDY; DISEASE ASSOCIATION; ENDOCRINE FUNCTION; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; LETTER; LIPID BLOOD LEVEL; METABOLISM; NONALCOHOLIC FATTY LIVER; PPAR GENE; PREVALENCE; PRIORITY JOURNAL; RNA TRANSLATION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

FATTY LIVER; FEMALE; HUMANS; LIVER DISEASES; MALE; OBESITY; OVERWEIGHT;

EID: 84897375637     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12649     Document Type: Letter

References (6)

1. Schwimmer JB, Newton KP, Awai HI, et al,. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013; 38: 1267-77.
2. Lonardo A, Carani C, Carulli N, Loria P,. 'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. J Hepatol 2006; 44: 1196-207.
3. Kurowska-Stolarska M, Alivernini S, Ballantine LE, et al,. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci USA 2011; 108: 11193-8.
4. Lavoie JM, Pighon A,. NAFLD, estrogens, and physical exercise: the animal model. J Nutr Metab 2012; 2012: 914938.
5. Peyrou M, Ramadori P, Bourgoin L, Foti M,. PPARs in liver diseases and cancer: epigenetic Regulation by microRNAs. PPAR Res 2012; 2012: 757803.
6. Sun Y, Sun J, Tomomi T, et al,. PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6. J Immunol 2013; 190: 4005-13.